Publications and communications of Yves Henrotin

Articles in scientific journals with peer reviewing

Raman, R., Antony, M., Nivelle, R., Lavergne, A., Zappia, J., Guerrero Limon, G., Caetano da Silva, C., Kumari, P., Sojan, J. M., Degueldre, C., Bahri, M. A., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., Renn, J., & Muller, M. (23 January 2024). The Osteoblast Transcriptome in Developing Zebrafish Reveals Key Roles for Extracellular Matrix Proteins Col10a1a and Fbln1 in Skeletal Development and Homeostasis. Biomolecules, 14 (2), 139. doi:10.3390/biom14020139

Raman, R., Bahri, M. A., Degueldre, C., Caetano da Silva, C., Sanchez, C., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., & Muller, M. (14 January 2024). A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis. Animals, 14 (1), 74. doi:10.3390/ani14010074

Henrotin, Y., Herman, J., Uebelhoer, M., Wauquier, F., Boutin-Wittrant, L., Donneau, A.-F., Monseur, J., Fotso, V. M., Duquenne, M., Wagner, M., Bouvret, E., Costes, B., & Wittrant, Y. (21 September 2023). Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation. BMC Musculoskeletal Disorders, 24 (1), 748. doi:10.1186/s12891-023-06800-4

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5

Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A.-F., Monseur, J., & Henrotin, Y. (22 June 2023). NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial. Frontiers in Nutrition, 10. doi:10.3389/fnut.2023.1137407

Henrotin, Y., Szekanecz, Z., & Masuko, K. (2023). Editorial: Reviews in rheumatology. Frontiers in Medicine, 10, 1153419. doi:10.3389/fmed.2023.1153419

Im, G.-I., & Henrotin, Y. (2023). Regenerative medicine for early osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 15, 1759720X231194813. doi:10.1177/1759720X231194813

Uebelhoer, M., Lambert, C., Grisart, J., Guse, K., Plutizki, S., & Henrotin, Y. (2023). Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. Frontiers in Medicine, 10, 1148623. doi:10.3389/fmed.2023.1148623

Conrozier, T., Diraçoglù, D., Monfort, J., Chevalier, X., Bard, H., Baron, D., Jerosch, J., Migliore, A., Richette, P., & Henrotin, Y. (2022). EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. Cartilage, 19476035221138958. doi:10.1177/19476035221138958

Holden, M. A., Metcalf, B., Lawford, B. J., Hinman, R. S., Boyd, M., Button, K., Collins, N. J., Cottrell, E., Henrotin, Y., Larsen, J. B., Master, H., Skou, S. T., Thoma, L. M., Rydz, R., Wellsandt, E., White, D. K., & Bennell, K. (2022). Recommendations for the delivery of therapeutic exercise for people with knee and/or hip osteoarthritis. An international consensus study from the OARSI Rehabilitation Discussion Group. Osteoarthritis and Cartilage. doi:10.1016/j.joca.2022.10.009

Henrotin, Y., Michlmayr, C., Rau, S. M., Quirke, A.-M., Bigoni, M., & Ueberall, M. A. (October 2022). Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature. Rheumatology and Therapy, 9 (5), 1305 - 1327. doi:10.1007/s40744-022-00472-7

Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914

Henrotin, Y., Cozannet, R. L., Fança-Berthon, P., Truillet, R., Cohen-Solhal, M., DunnGalvin, G., Grouin, J.-M., & Doolan, A. (07 July 2022). Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial. BMC Musculoskeletal Disorders, 23 (1), 650. doi:10.1186/s12891-022-05612-2

Angelini, F., Widera, P., Mobasheri, A., Blair, J., Struglics, A., Uebelhoer, M., Henrotin, Y., Marijnissen, A. C., Kloppenburg, M., Blanco, F. J., Haugen, I. K., Berenbaum, F., Ladel, C., Larkin, J., Bay-Jensen, A. C., & Bacardit, J. (2022). Osteoarthritis endotype discovery via clustering of biochemical marker data. Annals of the Rheumatic Diseases, 81 (5), 666-675. doi:10.1136/annrheumdis-2021-221763

Henrotin, Y. (2022). Osteoarthritis in year 2021: biochemical markers. Osteoarthritis and Cartilage, 30 (2), 237-248. doi:10.1016/j.joca.2021.11.001

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Costes, B., Verdonk, P., Brands, G., Brasseur, J., Urbin-Choffray, D., Vandenberghe, M., Brabants, K., De Vlam, K., Fache, W., Jandrain, B., Grek, V., MALAISE, M., & Henrotin, Y. (2022). An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X211070205. doi:10.1177/1759720X211070205

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855

Sanchez, C., Hemmer, K., Krömmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (11 May 2021). Reduction of Matrix Metallopeptidase 13 and Promotion of Chondrogenesis by Zeel T in Primary Human Osteoarthritic Chondrocytes. Frontiers in Pharmacology, 12, 1-12. doi:10.3389/fphar.2021.635034

Conrozier, T., Raman, R., Chevalier, X., Henrotin, Y., Monfort, J., Diraçoglù, D., Bard, H., Baron, D., Jerosch, J., Richette, P., & Migliore, A. (2021). Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group. Therapeutic Advances in Musculoskeletal Disease, 13. doi:10.1177/1759720X211018605

Henrotin, Y., Antoine, C., Zwerts, E., Neutelings, T., & Bouvret, E. (2021). Oral supplementation with fish cartilage hydrolysate accelerates joint function recovery in rat model of traumatic knee osteoarthritis. Food Science and Nutrition, 9 (6), 2877-2885. doi:10.1002/fsn3.2244

Holden, M. A., Button, K., Collins, N. J., Henrotin, Y., Hinman, R. S., Larsen, J. B., Metcalf, B., Master, H., Skou, S. T., Thoma, L. M., Wellsandt, E., White, D. K., & Bennell, K. (2021). Guidance for Implementing Best Practice Therapeutic Exercise for Patients With Knee and Hip Osteoarthritis: What Does the Current Evidence Base Tell Us? Arthritis Care and Research, 73 (12), 1746-1753. doi:10.1002/acr.24434

L'Hote, C., Cordier, B., Labasse, A., Boileau, C., Costes, B., & Henrotin, Y. (2021). Identification of new biomarkers for sarcopenia and characterization of cathepsin D biomarker. JCSM Rapid Communications, 4, 122-132. doi:10.1002/rco2.26

Lambert, C., Bellemère, G., Boyer, G., Ponelle, F., Bauer, T., Legeny, M.-C., Baudouin, C., & Henrotin, Y. (2021). Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis. Frontiers in Pharmacology, 12, 781389. doi:10.3389/fphar.2021.781389

Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186

Mobasheri, A., Fonseca, J. E., Gualillo, O., Henrotin, Y., Largo, R., Herrero-Beaumont, G., & Rocha, F. A. C. (2021). Editorial: Inflammation and Biomarkers in Osteoarthritis. Frontiers in Medicine, 8, 727700. doi:10.3389/fmed.2021.727700

Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019

Batshon, G., Elayyan, J., Qiq, O., Reich, E., Ben-Aderet, L., Kandel, L., Haze, A., Steinmeyer, J., Lefebvre, V., Zhang, H., Elisseeff, J., Henrotin, Y., Mobasheri, A., & Dvir-Ginzberg, M. (2020). Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence. Annals of the Rheumatic Diseases, 79 (10), 1370-1380. doi:10.1136/annrheumdis-2020-217072

Montjean, R., Escaich, S., Paolini, R., Carelli, C., Pirson, S., Neutelings, T., Henrotin, Y., & Vêtu, C. (2020). REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis. PLoS ONE, 15 (4), 0231240. doi:10.1371/journal.pone.0231240

Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080

Henrotin, Y. (February 2019). Les nouveaux biomarqueurs de l'arthrose. Lettre du Rhumatologue, 449, 16-19.

Boisson, M., Borderie, D., Henrotin, Y., Teboul-Coré, S., Lefèvre-Colau, M.-M., Rannou, F., & Nguyen, C. (2019). Serum biomarkers in people with chronic low back pain and Modic 1 changes: a case-control study. Scientific Reports, 9 (1). doi:10.1038/s41598-019-46508-x

de Visser, H. M., Sanchez, C., Mastbergen, S. C., Lafeber, F. P. J. G., Henrotin, Y., & Weinans, H. (2019). Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation. Cartilage, 10 (3), 329-334. doi:10.1177/1947603518754629

Elango, J., Saravanakumar, K., Rahman, S. U., Henrotin, Y., Regenstein, J. M., Wu, W., & Bao, B. (2019). Chitosan-collagen 3d matrix mimics trabecular bone and regulates rankl-mediated paracrine cues of differentiated osteoblast and mesenchymal stem cells for bone marrow macrophage-derived osteoclastogenesis. Biomolecules, 9 (5). doi:10.3390/biom9050173

Henrotin, Y., Bannuru, R., Malaise, M., Ea, H.-K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, J.-P., Thomas, P., Hick, A.-C., Marinello, A., Giordan, N., & Richette, P. (2019). Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: Data from MOKHA study. BMC Musculoskeletal Disorders, 20 (1). doi:10.1186/s12891-019-2667-0

Henrotin, Y., Malaise, M., Wittoek, R., De Vlam, K., Brasseur, J.-P., Luyten, F. P., Jiangang, Q., Van Den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., Donneau, A.-F., & Dierckxsens, Y. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study. Arthritis Research and Therapy, 21 (1). doi:10.1186/s13075-019-1960-5

Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Lambert, C., Davidson, R. K., Clark, I. M., Thornalley, P. J., Henrotin, Y., & Rabbani, N. (June 2018). Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research and Therapy, 20 (1), 131. doi:10.1186/s13075-018-1636-6

Elango, J., Lee, J., Wang, S., Henrotin, Y., De Val, J. E. M. S., Regenstein, J. M., Lim, S. Y., Bao, B., & Wu, W. (2018). Evaluation of differentiated bone cells proliferation by blue shark skin collagen via biochemical for bone tissue engineering. Marine Drugs, 16 (10), 350. doi:10.3390/md16100350

Elango, J., Sanchez, C., de Val, J. E. M. S., Henrotin, Y., Wang, S., Motaung, K. S. C. M., Guo, R., Wang, C., Robinson, J., Regenstein, J. M., Bao, B., & Wu, W. (2018). Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. Scientific Reports, 8 (1), 5318. doi:10.1038/s41598-018-23532-x

Henrotin, Y. (2018). Avocado/Soybean Unsaponifiables (Piacledine®300) show beneficial effect on the metabolism of osteoarthritic cartilage, synovium and subchondral bone: An overview of the mechanisms. AIMS Medical Science, 5 (1), 33-52.

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591

Sanchez, C., Bay-Jensen, A.-C., Pap, T., Dvir-Ginzberg, M., Quasnichka, H., Barrett-Jolley, R., Mobasheri, A., & Henrotin, Y. (August 2017). Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis. Osteoarthritis and Cartilage, 25, 1199-1209. doi:10.1016/j.joca.2017.02.797

Demoulin, C., Depas, Y., Vanderthommen, M., Henrotin, Y., Wolfs, S., Cagnie, B., & Hidalgo, B. (March 2017). LA THÉRAPIE MANUELLE ORTHOPÉDIQUE : définition, caractéristiques et mise au point sur la situation en Belgique. Revue Médicale de Liège, 72 (3), 126-131.

Bartels, E. M., Henrotin, Y., Bliddal, H., Centonze, P., & Henriksen, M. (2017). Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial. Osteoarthritis and Cartilage, 25 (10), 1641-1646. doi:10.1016/j.joca.2017.06.009

Comblain, F., Barthelemy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (2017). A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner's dogs with osteoarthritis. BMC Veterinary Research, 13, 395. doi:10.1186/s12917-017-1317-8

Henrotin, Y., Berenbaum, F., Chevalier, X., Marty, M., Richette, P., & Rannou, F. (2017). Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: The EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. BMC Musculoskeletal Disorders, 18 (1). doi:10.1186/s12891-017-1585-2

Lazzarini, N., Runhaar, J., Bay-Jensen, A. C., Thudium, C. S., Bierma-Zeinstra, S. M. A., Henrotin, Y., & Bacardit, J. (2017). A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women. Osteoarthritis and Cartilage, 25 (12), 2014-2021. doi:10.1016/j.joca.2017.09.001

Luo, Y., Sinkeviciute, D., He, Y., Karsdal, M., Henrotin, Y., Mobasheri, A., Önnerfjord, P., & Bay-Jensen, A. (2017). The minor collagens in articular cartilage. Protein and Cell, 8 (8), 560-572. doi:10.1007/s13238-017-0377-7

Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902

Henrotin, Y., Sanchez, C., Bay-Jensen, A. C., & Mobasheri, A. (June 2016). Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Annals of Physical and Rehabilitation Medicine, 59 (3), 145-148. doi:10.1016/j.rehab.2016.03.004

Runhaar, J.* , Sanchez, C.* , Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2016). Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis and Cartilage, 24 (4), 672-678. doi:10.1016/j.joca.2015.10.013
* These authors have contributed equally to this work.

Bay-Jensen, A.-C., Henrotin, Y., Karsdal, M., & Mobasheri, A. (2016). The need for predictive, prognostic, objective and complementary blood-based biomarkers in osteoarthritis (OA). EBioMedicine. doi:10.1016/j.ebiom.2016.05.004

Bay-Jensen, A. C., Reker, D., Kjelgaard-Petersen, C. F., Mobasheri, A., Karsdal, M. A., Ladel, C., Henrotin, Y., & Thudium, C. S. (2016). Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthritis and Cartilage, 24 (1), 9-20. doi:10.1016/j.joca.2015.10.014

Hochberg, M. C., Martel-Pelletier, J., Monfort, J., Moller, I., Castillo, J. R., Arden, N., Berenbaum, F., Blanco, F. J., Conaghan, P. G., Domenech, G., Henrotin, Y., Pap, T., Richette, P., Sawitzke, A., du Souich, P., Pelletier, J. P., & Group, M. I. (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases, 75 (1), 37-44. doi:10.1136/annrheumdis-2014-206792

Moller, I., Gharbi, M., Martinez Serrano, H., Herrero Barbero, M., Verges Milano, J., & Henrotin, Y. (2016). Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. BMC Musculoskeletal Disorders, 17 (1), 416. doi:10.1186/s12891-016-1268-4

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., Henrist, C., Compère, P., & Henrotin, Y. (28 May 2015). Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes. PLoS ONE, 10 (5). doi:10.1371/journal.pone.0128362

Comblain, F., Sanchez, C., Lesponne, I., Balligand, M., Serisier, S., & Henrotin, Y. (2015). Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator's Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer. PLoS ONE. doi:10.1371/journal.pone.0121654

Horcajada, M.-N.* , Sanchez, C.* , Membrez Scalfo, Drion, P., Comblain, F., Taralla, S., Donneau, A.-F., Offord, E. A., & Henrotin, Y. (2015). Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthritis and Cartilage, 23 (1), 94-102. doi:10.1016/j.joca.2014.08.016
* These authors have contributed equally to this work.

Mobasheri, A., & Henrotin, Y. (2015). Biomarkers of (osteo)arthritis. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 20 (8), 513-8. doi:10.3109/1354750X.2016.1140930

Richette, P., Chevalier, X., Ea, H. K., Eymard, F., Henrotin, Y., Ornetti, P., Sellam, J., Cucherat, M., & Marty, M. (2015). Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD Open, 1 (1), 000071. doi:10.1136/rmdopen-2015-000071

Sanchez, C., Horcajada, M.-N., Membrez Scalfo, F., Ameye, L., Offord, E., & Henrotin, Y. (2015). Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes. PLoS ONE, 10 (8), 0136118. doi:10.1371/journal.pone.0136118

McAlindon, T. E., & Henrotin, Y. (March 2014). OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 22 (3), 363-388. doi:10.1016/j.joca.2014.01.003

Henrotin, Y. (2014). Does signalling pathways inhibition hold therapeutic promise for osteoarthritis? Joint Bone Spine, 81, 281-283. doi:10.1016/j.jbspin.2014.03.002

Henrotin, Y. (2014). Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complementary and Alternative Medicine. doi:10.1186/1472-6882-14-159

Henrotin, Y., Marty, M., & Mobasheri, A. (2014). What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas, 78, 184-187. doi:10.1016/j.maturitas.2014.04.015

Dobson, F., & Henrotin, Y. (October 2013). OARSI recommended performance-based tests to assess clinical function in osteoathritis of hip and knee: author's reply. Osteoarthritis and Cartilage, 21 (10), 1625-1626.

Henrotin, Y., Labasse, A., Franck, T., Bosseloir, A., Bury, T., & DEBERG, M. (2013). Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. SpringerPlus, 2 (1), 92. doi:10.1186/2193-1801-2-92

Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (March 2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research and Therapy, 14 (2), 58. doi:10.1186/ar3771

Henrotin, Y. (2011). Muscle: a source of progenitor cells for bone fracture healing. BMC Medicine, 9, 136. doi:10.1186/1741-7015-9-136

Mathy, C., Broonen, J.-P., Henrotin, Y., Marty, M., Legout, V., Genevay, S., Duplan, B., Bazin, T., Laroche, F., Savarieau, B., & Cedraschi, C. (2011). Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients. BMC Musculoskeletal Disorders, 12, 111. doi:10.1186/1471-2474-12-111

Henrotin, Y., & Chevalier, X. (2010). Recommandations sur la prise en charge de l'arthrose de la hanche et du genou. Pour qui ? Pourquoi ? Pour quoi faire ? Presse Médicale. doi:10.1016/j.lpm.2010.03.029

Lejeune, J.-P., Serteyn, D., Gangl, M., Schneider, N., Deby-Dupont, G., Deberg, M., & Henrotin, Y. (July 2007). Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications, 31 (5), 591-601. doi:10.1007/s11259-007-3518-2

Gangl, M., Deberg, M., Lejeune, J.-P., Schneider, N., Grulke, S., Peters, F., Vila, T., Deby-Dupont, G., Serteyn, D., & Henrotin, Y. (2007). A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Research in Veterinary Science, 82, 68-75. doi:10.1016/j.rvsc.2006.03.008

Demoulin, C., Fauconnier, C., Vanderthommen, M., & Henrotin, Y. (2005). Recommandations pour l'elaboration d'un bilan fonctionnel de base du patient lombalgique. Revue Médicale de Liège, 60 (7-8, Jul-Aug), 661-8.

Bruyère, O., Henrotin, Y., Honore, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (April 2003). Impact of the joint space width measurement method on the design of knee osteoarthritis studies. Aging Clinical and Experimental Research, 15 (2), 136-41. doi:10.1007/BF03324491

Reginster, J.-Y., Paul, I., & Henrotin, Y. (July 2001). Comment positionner l'acéclofénac au sein de l'arsenal thérapeutique des pathologies ostéo-articulaires chroniques ? Revue Médicale de Liège, 56 (7), 484-8.

Henrotin, Y., Deby-Dupont, G., & Reginster, J.-Y. (June 2001). Les mediateurs biochimiques de l'inflammation. Revue Médicale de Liège, 56 (6), 433-42.

Reginster, J.-Y., & Henrotin, Y. (March 2001). Pharma clinics. Comment je traite.... L'arthrose. 2eme partie: Nouvelles perspectives therapeutiques. Revue Médicale de Liège, 56 (3), 135-9.

Reginster, J.-Y., & Henrotin, Y. (February 2001). Pharma clinics. Comment je traite.... L'arthrose. 1ère partie: Rappel physiopathologique et traitement symptomatique. Revue Médicale de Liège, 56 (2), 63-7.

Reginster, J.-Y., Henrotin, Y., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69 (3), 130-137. doi:10.1007/s002230020042

Patents

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (30 January 2019). OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (27 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (25 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Lambert, C., Borderie, D., & Rannou, F. (23 June 2016). Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment.

Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (20 January 2016). Biomarker for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (18 November 2014). Intra-articularly supplementation method for treating joint diseases and injuries.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (11 November 2014). Cell cultivation in chitosan alginate hydrogel beads.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (02 January 2013). An intra-articular supplement for use in treating joint diseases and injuries.

Scientific conferences in universities or research centers

Henrotin, Y. (04 December 2015). Les marqueurs biologiques de l'arthrose : de la découverte à l'industrialisation [Paper presentation]. Université de Nantes, Nantes, France.

Scientific congresses and symposiums

Published communications

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (30 May 2023). Urolithin A and B accelerate myocyte fusion into myotubes. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1926-1927. doi:10.1136/annrheumdis-2023-eular.3536

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (30 May 2023). Osteomodulin down-regulation is associated with osteoarthritis development. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1194-1195. doi:10.1136/annrheumdis-2023-eular.1006

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (March 2023). Deciphering Urolithins A And B Activities On Muscle: Transcriptomic Modulation On Human Primary Myotubes. Osteoarthritis and Cartilage, 31, 303. doi:10.1016/j.joca.2023.01.316

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (March 2023). Osteomodulin Is Involved In Bone And Cartilage Homeostasis And Osteoarthritis Development. Osteoarthritis and Cartilage, 31, 323-S324. doi:10.1016/j.joca.2023.01.350

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (December 2022). Évaluation de l’activité des urolithines A et B sur le muscle : modulation transcriptomique sur les myotubes primaires humains. Revue du Rhumatisme, 89, 49-A50. doi:10.1016/j.rhum.2022.10.061

Zappia, J., Van Der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Lories, R., Elewaut, D., Sanchez, C., & Henrotin, Y. (December 2022). L’ostéomoduline joue un rôle majeur dans l’homéostasie de l’os et du cartilage. Revue du Rhumatisme, 89, 176. doi:10.1016/j.rhum.2022.10.261

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (April 2021). Development of a primary skeletal muscle cell culture model from human muscle biopsies. Osteoarthritis and Cartilage, 29 (Suppl), 108.

Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin Impacts Positively The Bone Remodeling Process In Osteoarthritis. Bone Reports, 14 (Suppl 1), 2352-1872. doi:10.1016/j.bonr.2021.100904

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (December 2020). Mise au point d’un modèle de culture original de cellules musculaires squelettiques à partir de biopsies musculaires humaines. Revue du Rhumatisme, Volume 87 (Supplément 1). doi:10.1016/j.rhum.2020.10.433

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboudjian, M., Hick, A.-C., Costes, B., Garcia, L., & Henrotin, Y. (June 2020). An oleuropein-based dietary supplement improves joint functionality in older people with hugh knee joint pain. Annals of the Rheumatic Diseases, 79 (Suppl 1), 930.

Sanchez, C., Hemmer, K., Kroemmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (June 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336.

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (June 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336-1337.

Henrotin, Y., Hick, A.-C., Labasse, A., Pelousse, F., Lemaire, J.-M., Helleputte, T., Cobraiville, E., Pirson, S., Garcia, L., & Costes, B. (April 2020). Cartilage biomarkers S-COLL2-1 and S-COLL2-1NO2 are helpful in identifying knee osteoarthritis patients at risk of disease worsening. Osteoarthritis and Cartilage, 28 (Suppl 1), 327-28.

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Hick, A.-C., Costes, B., Garcia, L., & Henrotin, Y. (April 2020). An oleuropein-based dietary supplement improves joint functionality in older people with high knee joint pain. Osteoarthritis and Cartilage, 28 (Suppl 1), 472-3.

Sanchez, C., Hemmer, K., Krommelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (April 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Osteoarthritis and Cartilage, 28 (Suppl 1), 106-107. doi:10.1016/j.joca.2020.02.171

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (April 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Osteoarthritis and Cartilage, 28 (Suppl 1), 120.

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (June 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Annals of the Rheumatic Diseases, 78 (Suppl 2), 1508.

Sanchez, C., Lambert, C., Dubuc, J., Bertrand, J., Pap, T., & Henrotin, Y. (November 2018). Le syndécan-4 est un marqueur de l’hypertrophie des chondrocytes du genou arthrosique. Revue du Rhumatisme, 85S, 327.

Henrotin, Y., Bannuru, R. R., Malaise, M., EA, K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, Thomas, T., Marrinello, A., Giordan, N., & Richette, P. (June 2018). HYALURONAN DERIVATIVE HYMOVIS® INCREASES CARTILAGE VOLUME AND TYPE II COLLAGEN TURNOVER IN OSTEOARHRITIC KNEE: DATA FROM MOKHA STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 1614.

Henrotin, Y., Malaise, M., Wittoek, R., Devlam, K., Brasseur, J.-P., Luyten, F., Jiangang, Q., Van den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., & Dierckxsens, Y. (June 2018). EFFICACY OF BIO-OPTIMISED CURCUMA EXTRACT (FLEXOFYTOL®) FOR PAINFUL KNEE OSTEOARTHRITIS: DATA FROM COPRA, A MULTICENTER RANDOMISED CONTROLLED STUDY. Annals of the Rheumatic Diseases, 77 (supplement 2), 790.

Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (June 2018). THE COLL2–1 PEPTIDE OF COLLAGEN TYPE II: A NEW ACTOR OF SYNOVITIS IN OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 890.

Rabbani, N., Ahmed, U., Lambert, C., Legrand, C., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., & Henrotin, Y. (June 2018). GLUCOSEPANE : A NEW BIOMARKER OF THE SEVERITY OF OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 181.

Sanchez, C., Mazzucchelli, G., Comblain, F., Lambert, C., De Pauw, E., & Henrotin, Y. (June 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Annals of the Rheumatic Diseases, 77 (supplement 2), 894.

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (April 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Osteoarthritis and Cartilage, 26 (supplement 1), 89. doi:10.1016/j.joca.2018.02.192

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (December 2017). L’analyse protéomique du sécrétome des ostéoblastes fournis de nouvelles indications sur les mécanismes de la sclérose sous-chondrale dans l’arthrose. Revue du Rhumatisme, 84 (S1), 295.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs. Osteoarthritis and Cartilage, 25, 314-s315.

Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (2017). Le peptide Coll2-1 du collagène de type II : un nouvel acteur de la synovite dans l’arthrose. Revue du Rhumatisme, 84S, 50.

Lambert, C., Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., Rabbani, N., & Henrotin, Y. (2017). Le glucosépane : un nouveau marqueur de la sévérité de l’arthrose. Revue du Rhumatisme, 84S, 102.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (November 2016). Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley. Revue du Rhumatisme, 83S, 209-A210. doi:10.1016/S1169-8330(16)30512-9

Möller, I., Gharbi, M., Martinez, H., Herrero, M., Verges, J., & Henrotin, Y. (June 2016). Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: how to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. Annals of the Rheumatic Diseases, 75 (Suppl 2), 1167. doi:10.1136/annrheumdis-2016-eular.3425

Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (April 2016). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Osteoarthritis and Cartilage, 24 (suppl 1), 88.

Sanchez, C., Lambert, C., Comblain, F., Legrand, C., & Henrotin, Y. (April 2016). Osteoarthritic sclerotic subchondral osteoblasts secreted elevated concentration of fibulin-3 fragments in vitro. Osteoarthritis and Cartilage, 24 (suppl 1), 83.

Chevalier, X., Bard, H., Migliore, A., Henrotin, Y., Monfort, J., Conrozier, T., Raman, R., Baron, D., Jerosch, J., & Richette, P. (2016). Recommandations du groupe EUROVISCO pour le retraitement par acide hyaluronique des patients préalablement traités par viscosupplémentation pour une gonarthrose. Revue du Rhumatisme, 83, 124-A125. doi:10.1016/S1169-8330(16)30400-8

Runhaar, J., Sanchez, C., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2015). Baseline Fibulin3 concentrations are associated with incidence of clinical knee OA after 30 months in overweight and obese women. Osteoarthritis and Cartilage, 23 (S2), 83. doi:10.1016/j.joca.2015.02.782

Henrotin, Y. (2015). Biomarkers of prognosis and efficacy of treatment in OA. BMC Musculoskeletal Disorders, 16 (suppl 1). doi:10.1186/1471-2474-16-S1-S2

Runhaar, Sanchez, C., Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (2015). Baseline Fibulin3 Concentrations Are Associated with Incidence of Clinical Knee OA after 30 Months in Overweight and Obese Women. Arthritis and Rheumatism, 67 (Suppl10).

Reginster, J.-Y., Henrotin, Y., Bruyère, O., Gonzalez, C., Giacovelli, G., & Rovati, L. C. (June 2002). Joint space narrowing is poorly correlated with symptoms worsening in knee-osteoarthritis: results from the prospective follow-up of 106, placebo-treated patients for three years. Annals of the Rheumatic Diseases, 61 (Suppl.1), 121.

Reginster, J.-Y., Henrotin, Y., Deroisy, R., Giacovelli, G., Gonzalez, C., & Rovati, L. (June 2002). Correlation between mean and minimum joint space measurements in a long-term trial with glucosamine sulfate, an osteoarthritis modifying agent. Annals of the Rheumatic Diseases, 61 (Suppl.1).

Reginster, J.-Y., Rovati, L., Deroisy, R., Henrotin, Y., Gatterova, J., Machacek, S., Gonzalez, C., Giacovelli, G., & Pavelka, K. (June 2002). Glucosamine sulfate slows-down osteoarthritis progression in postmenopausal women: pooled analysis of two large, independent, randomised, placebo-controlled, double-blind, prospective 3-year trials. Annals of the Rheumatic Diseases, 61 (Suppl.1).

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Tissue Engineering, 7 (5), 648.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Tissue Engineering, 7 (5), 648.

Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Annals of the Rheumatic Diseases, 60 (suppl1), 284.

Oral communications or posters

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (07 October 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes [Paper presentation]. 15th World Congress of ICRS, Vancouver, Canada.

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (02 October 2019). Development of a muscle cell culture model from human muscle biopsies [Poster presentation]. EORS 2019, Maastricht, Netherlands.

Florin, A., Lambert, C., Sanchez, C., Durieux, N., Mobasheri, A., & Henrotin, Y. (04 April 2019). Sécrétome des cellules musculaires squelettiques: revue systématique de la littérature [Paper presentation]. Congrès Fragilité du sujet âgé, Paris, France.

Henrotin, Y., Cordier, B., Labasse, A., VanderPoelen, S., Boileau, C., Costes, B., & L'hote, C. (April 2019). Identification et caractérisation de nouveaux biomarqueurs de la sarcopénie [Paper presentation]. Fragilité du sujet âgé, Paris, France.

Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (20 February 2019). The secretome of skeletal muscle cells: A systematic review [Poster presentation]. International Conference on Frailty & Sarcopenia Research, Miami, United States.

Raman, R., Zappia, J., Dinh Duy Thanh, Henrotin, Y., & Muller, M. (2019). Isolation of Osteoblast RNA from Danio rerio larvae – presenting a novel method or an update to the existing one ! [Poster presentation]. 2nd EDT PhD Student Day, Brussels, Belgium.

Rahnamay Moshtagh, P., Korthagen, N., Plomp, S., Pouran, B., Sanchez, C., Henrotin, Y., Zadpoor, A., & Weinans, H. (2017). Effect of moderate increasing exercice on the mechanical balance of the knee joint in young rats [Paper presentation]. 2017 OARSI World Congress on Osteoarthritis Promoting Clinical and Basic Research in Osteoarthritis, Las Vegas, United States - Nevada.

Henrotin, Y. (04 February 2016). Bien soigner l'arthrose: un enjeu de société [Paper presentation]. Grandes Conférences, Mons, Belgium.

Henrotin, Y. (16 January 2016). Biomarqueurs dans l'arthrose et acide hyaluronique [Paper presentation]. 15ème congrès national de la Fédération Française de Rhumatologie, Paris, France.

Henrotin, Y. (07 January 2016). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Gand, Belgium.

Henrotin, Y. (15 December 2015). Arthrose rachidienne lombaire: une réalité? comment la définir? [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, France.

Henrotin, Y. (14 December 2015). L’injection intra-articulaire de KARTILAGE CROSS® réduit le taux sérique de Coll2-1, un marqueur spécifique de la dégradation du cartilage: résultats de l’étude prospective, multicentrique, randomisée, en double aveugle et contrôlée EPIKART [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, France.

Henrotin, Y. (14 December 2015). Des peptides spécifiques de la Fibuline-3 sont prédictifs de l’arthrose du genou chez les femmes en surpoids ou obèses [Paper presentation]. 28ème Congrès de la Société Française de Rhumatologie, Paris, Belgium.

Henrotin, Y. (13 December 2015). Syndrome metabolique: prise en charge par le kinésithérapeute [Paper presentation]. le syndrome métabolique, Marche-en-Famenne, Belgium.

Henrotin, Y. (12 December 2015). Ha INTRAARTICULAR INJECTION: THERAPEUTIC AND ECONOMIC CONSIDERATIONS [Paper presentation]. Seminars in MSK radiology, Bruxelles, Belgium.

Henrotin, Y. (26 November 2015). Les marqueurs biologiques de l'arthrose : de la conception à la qualification [Paper presentation]. Institut Servier, Paris, France.

Henrotin, Y. (17 November 2015). Les biomarqueurs de l'arthrose [Paper presentation]. Programme UE-1 (22U1OA53), Paris, France.

Henrotin, Y. (16 November 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Tournai, Belgium.

Henrotin, Y. (07 November 2015). Prise en charge non pharmacologique de la gonarthrose; actualités et perspectives [Paper presentation]. Congrès International de médecine du sport, Charleroi, Belgium.

Henrotin, Y. (07 November 2015). L'ostéopathie: mythe ou réalité? [Paper presentation]. Collaque l'arthrose dans tous ses états, Paris, France.

Henrotin, Y. (05 November 2015). Biomakers of osteoarthritis [Paper presentation]. State of art in Exercices physiology.

Sanchez, C., Runhaar, J., Taralla, S., Bierma-Zeinstra, S. M. A., & Henrotin, Y. (November 2015). Des peptides spécifiques de la fibuline-3 sont prédictifs de l’incidence de l’arthrose du genou chez les femmes en surpoids ou obèses [Paper presentation]. 28ème Congrès Français de Rhumatologie, Paris, France.

Henrotin, Y. (20 October 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Ottignie, Belgium.

Henrotin, Y. (02 October 2015). Significant reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) following Viscosupplementation Compared to saline solution in patients with Knee Osteoarthritis [Paper presentation]. 3rd International symposium on intra-articular treatment - ISIAT 2015, Budapest, Hungary.

Henrotin, Y. (02 October 2015). Novel chitosan hydrogel for the treatment of osteoarthritis [Paper presentation]. 3rd International symposium on intra-articular treatment - ISIAT 2015, Budapest, Hungary.

Henrotin, Y. (29 September 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Hasselt, Belgium.

Henrotin, Y. (18 September 2015). Soluble biomarkers in OA: can they be used as indicator of HA re-injection? [Paper presentation]. Labhra Europen Board 2 edition, Lyon, France.

Henrotin, Y. (17 September 2015). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Bruge, Belgium.

Henrotin, Y. (01 July 2015). Biomarkers of prognosis and efficacy of reatment [Paper presentation]. Congress of the Institute of Advanced Studies, Surrey, United Kingdom.

Henrotin, Y. (27 June 2015). Légitimité des recommAndations sur la viscosupPlementation [Paper presentation]. Journée nationale du GRIFF, Ste Maxime, France.

Henrotin, Y. (02 April 2015). Pourra-t-on prédire la sévérité d’une arthrose dés son début? OUI, grâce aux biomarqueurs [Paper presentation]. 60ème semaine de rhumatologie, Aix-les-Bains, France.

Henrotin, Y. (03 March 2015). HA viscosupplEmentation in OA treatment [Paper presentation]. advisory board in rheumatology - current and future treatment option in osteoarthitis, Paris, France.

Henrotin, Y. (24 January 2015). Quels produits injecterons nous demain dans nos articulations? [Paper presentation]. 3ème journéée de rhumatologie interventionnelle, Paris, France.

Henrotin, Y. (06 December 2014). Innovation dans l'arthrose [Paper presentation]. 27ème congrès français de rhumatologie, Paris, France.

Henrotin, Y. (04 December 2014). L'exercice physique: le traitement de choix de la lombalgie [Paper presentation]. La lombalgie, Marche-en-Famenne, Belgium.

Henrotin, Y. (25 October 2014). Biomarkers of prognosis and efficacy of treatment [Paper presentation]. World Congress on Controversies, Debates & Consensus in Veterinary Medicine, Praha, Czechia.

Henrotin, Y. (24 October 2014). Nutraceuticals for joint healthand biomarkers [Paper presentation]. World Congress on Controversies, Debates & Consensus in Veterinary Medicine, Praha, Czechia.

Henrotin, Y. (20 October 2014). Bien soigner l'arthrose: un enjeu capital pour notre société! [Paper presentation]. Grandes conférences, Louvain-la-neuve, Belgium.

Henrotin, Y. (11 October 2014). Prise en charge de la gonarthrose [Paper presentation]. Société Algérienne de Rhumatologie, Alger, Algeria.

Henrotin, Y. (12 June 2014). biochemical markers to monitor the effects of drugs in knee OA patient [Paper presentation]. Symposium stellite BioIberica, Paris, France.

Henrotin, Y. (26 April 2014). Les vertiges: ça se soigne! [Paper presentation]. Conférence, Marche-en-Famenne, Belgium.

Henrotin, Y. (24 April 2014). Recent advances and innavation in viscosupplementation [Paper presentation]. Orthopaedica Belgica 2014.

Henrotin, Y. (24 April 2014). Disease Modifying drugs for OA: from research to clinical evidences [Paper presentation]. Orthopaedica Belgica 2014, Anvers, Belgium.

Henrotin, Y. (02 December 2013). Physiopathologie du MODIC [Paper presentation]. 26eme congrès français de rhumatologie, Paris, France.

Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (November 2013). SYNERGISTIC BENEFICIAL EFFECTS OF CURCUMA EXTRACT, GREEN TEA EXTRACT AND HYDROLYZED COLLAGEN IN BOVINE CHONDROCYTES IN MONOLAYER CULTURE [Poster presentation]. Bone, Muscle & Joint Diseases 2013, Brussels, Belgium.

Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (02 October 2013). Synergistic beneficial effects of curcuma extract, green tea extract and hydrolysed collagen in bovine chondrocytes in monolayer culture [Paper presentation]. Waltham International Nutritional Sciences Symposium 2013, Portland, United States - Oregon.

Henrotin, Y. (18 April 2012). New alginate-chitosan hydrogel to repair cartilage [Paper presentation]. Congrès Biomedica, Liège, Belgium.

Book chapters and contributions to collective works

Henrotin, Y. (2019). Glucosamine et chondroitine: un intérêt majeur pour les articulations. In Les cahiers des compléments alimentaires - l'intégral (pp. 69-70). Paris, France: Synadiet.

Henrotin, Y. (2019). Glucosamine et chondroïtine : à titre préventif pour diminuer les coûts liés à l’arthrose. In Les cahiers des compléments alimentaires - l'abrégé (pp. 6-7). Paris, France: Synadiet.

Henrotin, Y. (2016). Les marqueurs biologiques de l'arthrose : de la conception à la qualification. In Institut Servier, De l'arthrose aux arthroses (pp. 58-67). Paris, France: Springer.

Theses and dissertations

Post-doctoral thesis

Henrotin, Y. (2003). Approche expérimentale de la pathogénie et du traitement de l'arthrose [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/193172

Doctoral thesis

Henrotin, Y. (1994). Production de protéines matricielles, de cytokines et de formes activées de l'oxygène par les chondrocytes articulaires humains in vitro [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/193173

Other publications and communications

Articles in scientific journals without peer reviewing

Henrotin, Y. (20 November 2024). Influence of the Covid-19 Pandemic on the Algo- Functional Status and the General Health of Osteoarthritis Patients. Archive of Pharmacy and Pharmacology Research, 3 (5), 1-8. doi:10.33552/APPR.2023.03.000573

Bjerre-Bastos, J. J., Hamrouni, N., Henrotin, Y., Thudium, C. S., & Bihlet, A. R. (December 2023). Joint biomarker response to mechanical stimuli in osteoarthritis - A scoping review. Osteoarthritis and Cartilage Open, 5 (4), 100390. doi:10.1016/j.ocarto.2023.100390

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Henrotin, Y., Donneau, A.-F., De Vlam, K., Wittoek, R., & Luyten, F. (2020). Responses to "bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study": Authors' reply [letter to the editor]. Arthritis Research and Therapy, 22 (1). doi:10.1186/s13075-020-2109-2

Speeches and writings for a general audience

Conferences given outside the academic context

Henrotin, Y. (2016). Bien soigner l'arthrose, un enjeu capital pour notre société [Paper presentation]. Conférence annuelle, Herstal, Belgium.